Specialty Pharma Journal Specialty, Precision & Technology

INGELHEIM, Germany & SEONGNAM, Korea–(BUSINESS WIRE)–Boehringer Ingelheim and Bridge Biotherapeutics Inc. today announced that they …

PITTSBURGH, July 18, 2019 (GLOBE NEWSWIRE) — Predictive Oncology (Nasdaq: POAI) subsidiary Helomics, an artificial …

MEDFORD, N.Y., July 18, 2019 (GLOBE NEWSWIRE) — Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading …

PALO ALTO, Calif.–(BUSINESS WIRE)–LifeMax Laboratories, Inc. (“LifeMax”), a private company focused on treating rare diseases …

STAINES-UPON-THAMES, United Kingdom and LONDON, July 18, 2019 /PRNewswire/ — Mallinckrodt plc (NYSE: MNK), a global biopharmaceutical company, and Silence Therapeutics plc (LON: SLN), …

WHIPPANY, N.J. & PRINCETON, N.J. & OSAKA, Japan–(BUSINESS WIRE)–Bayer, Bristol-Myers Squibb Company (NYSE: BMY) and Ono Pharmaceutical …

KENILWORTH, N.J.–(BUSINESS WIRE)–Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced …

AUSTIN, Texas, July 17, 2019 /PRNewswire/ — Elios Therapeutics, a biopharmaceutical company developing innovative autologous, …

PASADENA, Calif.–(BUSINESS WIRE)–Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced that the U.S. Food and Drug …

STAINES-UPON-THAMES, United Kingdom, July 16, 2019 /PRNewswire/ — Mallinckrodt plc (NYSE: MNK), a leading global specialty biopharmaceutical company, today announced …

TOKYO and LONDON, July 16, 2019 /PRNewswire/ — Sosei Group Corporation (“the Company”) (TSE: 4565) …

CAMBRIDGE, Mass., July 16, 2019 (GLOBE NEWSWIRE) — LogicBio Therapeutics, Inc. (NASDAQ:LOGC), a genome editing …

BOTHELL, Wash. & TOKYO–(BUSINESS WIRE)–Seattle Genetics, Inc. (Nasdaq:SGEN) and Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji …

WALTHAM, Mass., July 16, 2019 /PRNewswire/ — Skyhawk Therapeutics, Inc. (Skyhawk) today announced that it …

Basel, July 16, 2019 – Novartis today announced the US Food and Drug Administration (FDA) accepted …